Author correction to ‘Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects’ [Acta Pharmaceutica Sinica B 13 (2023) 2138–2151] - Wei, Wei; Zeng, Qingxuan; Wang, Yan; Guo, Xixi; Fan, Tianyun; Li, Yinghong; Deng, Hongbin; Zhao, Liping; Zhang, Xintong; Liu, Yonghua; Shi, Yulong; Zhu, Jingyang; et al. (Acta pharmaceutica Sinica. B, 2024)